IceCure Medical Highlights Milestone at Upcoming Summit

Author: Evelyn Baker Updated: 10-09-2025 09:17 AM

IceCure Medical's Significant Advancement

IceCure has reached an important milestone with its ProSense cryoablation system, becoming the first medical device to receive FDA marketing authorization for the localized treatment of breast cancer. This marks a revolutionary achievement in the field of minimally invasive cancer treatment.

Participation in the Maxim Growth Summit

The management team at IceCure Medical, including CEO Eyal Shamir, will take part in the upcoming Maxim Growth Summit. This event is designed for meaningful interactions with institutional investors, allowing a closer look at IceCure's latest developments, regulatory achievements, and commercial progress both in the U.S. and internationally.

Innovative Cryoablation Technology

The ProSense system is a groundbreaking approach to treating early-stage breast cancer in patients aged 70 and older, particularly those who may not be suitable for surgery. This innovative technology serves as a new option, potentially transforming healthcare standards for these patients.

Investor Engagement Opportunities

Investors interested in setting up meetings with IceCure Medical's management during the summit can do so through their Maxim sales representatives or by contacting Michael Polyviou directly via email.

About IceCure Medical

IceCure Medical, traded under NASDAQ: ICCM, focuses on developing and marketing advanced cryoablation systems. Their technology uses liquid nitrogen to freeze and destroy tumors effectively. With a primary emphasis on cancers affecting the breast, kidney, bone, and lung, IceCure's system represents a significant shift in treatment methodologies, allowing for procedures that are less invasive and can be performed more swiftly. Their ProSense system is already being marketed globally, affirming its wide-ranging acceptance and potential.

Frequently Asked Questions

What significant milestone did IceCure Medical recently achieve?

IceCure Medical's ProSense cryoablation system received FDA marketing authorization for local breast cancer treatment.

Who from IceCure Medical will attend the Maxim Growth Summit?

CEO Eyal Shamir and members of the management team will participate in the summit.

What is the focus of IceCure Medical's cryoablation technology?

The technology focuses on treating various types of cancer, particularly in older patients who are not suitable for surgery.

How can investors engage with IceCure during the summit?

Investors can meet IceCure's management by reaching out to their Maxim sales representatives or contacting Michael Polyviou.

Where is IceCure Medical's ProSense system marketed?

The ProSense system is marketed globally, including in the U.S., Europe, and Asia, showcasing its international reach.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.